Valeritas Holdings ROA 2015-2018 | VLRX

Current and historical return on assets (ROA) values for Valeritas Holdings (VLRX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Valeritas Holdings ROA for the three months ending September 30, 2018 was -102.96%.
Valeritas Holdings ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.05B $0.05B -115.25%
2018-06-30 $-0.05B $0.05B -105.82%
2018-03-31 $-0.05B $0.03B -101.49%
2017-12-31 $-0.05B $0.05B -84.65%
2017-09-30 $-0.05B $0.06B -79.65%
2017-06-30 $-0.04B $0.07B -81.48%
2017-03-31 $-0.04B $0.07B -82.00%
2016-12-31 $-0.05B $0.04B -146.03%
2016-09-30 $-0.05B $0.04B -157.38%
2016-06-30 $-0.05B $0.05B -265.00%
2016-03-31 $-0.06B $0.00B -761.29%
2015-12-31 $-0.04B $0.03B -541.94%
2015-09-30 $-0.03B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.010B $0.020B
Valeritas Holdings Inc. is a commercial-stage medical technology company which focused on developing technologies for Type 2 diabetes. The company's product pipeline consists of V-Go (R) Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for Type 2 diabetes which enables patients to administer a continuous preset basal rate infusion of insulin. Valeritas Holdings Inc. is headquartered in Bridgewater, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.673B 26.23
Medtronic (MDT) Ireland $124.635B 18.20
Stryker (SYK) United States $69.927B 25.67
Boston Scientific (BSX) United States $55.591B 27.10
Baxter (BAX) United States $39.448B 24.31
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Canopy Growth (CGC) Canada $10.742B 0.00
Bio-Rad Laboratories (BIO) United States $8.172B 52.25
Aurora Cannabis (ACB) Canada $7.060B 50.50
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
ICU Medical (ICUI) United States $5.184B 28.88
Insulet (PODD) United States $5.071B 0.00
Haemonetics (HAE) United States $4.540B 40.28
GW Pharmaceuticals (GWPH) United Kingdom $4.400B 0.00
Agios Pharmaceuticals (AGIO) United States $3.380B 0.00
Hutchison China MediTech (HCM) China $3.329B 0.00
Neogen (NEOG) United States $3.267B 50.18
NuVasive (NUVA) United States $2.850B 24.96
Quidel (QDEL) United States $2.761B 24.91
National Vision Holdings (EYE) United States $2.637B 51.01
Aphria (APHA) $2.539B 112.78
NxStage Medical (NXTM) United States $2.000B 0.00
AtriCure (ATRC) United States $1.274B 0.00
HEXO (HEXO) $1.242B 0.00
Cardiovascular Systems (CSII) United States $1.240B 890.25
Phibro Animal Health (PAHC) United States $1.220B 17.53
VAREX IMAGING (VREX) United States $1.212B 23.73
MacroGenics (MGNX) United States $0.939B 0.00
Cerus (CERS) United States $0.904B 0.00
PetIQ (PETQ) United States $0.867B 22.47
Lantheus Holdings (LNTH) United States $0.847B 22.95
Surmodics (SRDX) United States $0.785B 114.20
Meridian Bioscience (VIVO) United States $0.733B 21.85
NanoString Technologies (NSTG) United States $0.721B 0.00
OraSure Technologies (OSUR) United States $0.720B 31.76
Omeros (OMER) United States $0.719B 0.00
Evolus (EOLS) United States $0.705B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.647B 20.75
LeMaitre Vascular (LMAT) United States $0.603B 28.76
Quanterix (QTRX) United States $0.518B 0.00
Insys Therapeutics (INSY) United States $0.426B 0.00
Owens & Minor (OMI) United States $0.408B 5.65
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.329B 445.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.294B 0.00
Vapotherm (VAPO) United States $0.288B 0.00
Bovie Medical (APYX) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Zynex (ZYXI) United States $0.174B 16.84
Fonar (FONR) United States $0.144B 7.70
Surface Oncology (SURF) United States $0.140B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.078B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.20
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14